The team at Advokatfirman Delphi routinely handles a range of capital market and health data mandates within the life sciences and healthcare sector. Alongside this, the team has experience in a broad array of transactions, public procurement, and IP matters, where they advise large and medium-sized companies. Elisabeth Eklund co-heads the team, providing a wealth of experience in competition law and regulatory matters within the life sciences sector. Leading the practice alongside her, Mats Dahlberg is a key contact for capital market transactions, such as IPOs and spin-offs.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Ability to provide legal expertise relevant to the specific business needs. Very proactive and relevant.'
- ‘Expert knowledge within multiple areas - great ability to provide a team covering all needed services.'
- ‘Straightforward communication, driven by facts, and professional.’
- ‘The team is highly responsive and demonstrates a solid understanding of the external environment in healthcare. They have valuable contacts with key stakeholders, which enhances their effectiveness. Additionally, their good availability makes collaboration smooth and reliable. Overall, a professional and well-connected firm!’
- ‘Elisabeth Eklund, Magnus Berterud, and Martin Bogg are outstanding, knowledgeable, and service-minded. ’
Key clients
- Attendo Sverige AB CycleZyme AB (publ) Enorama Pharma AB (publ) ForMotion AB Hamlet BioPharma AB Johnson & Johnson Innovative Medicine Lindex Sverige AB Malmhill NordicInfu Care AB Pareto Securities Paxman AB Pharmacosmos A/S Phase Holographic Imaging PHI AB (publ) PolarCool AB (publ) ProstaLund AB (publ) Signet Healthcare Partners Simris Group AB (publ) Suicide Zero
Work highlights
Represented Lindex Sverige AB in a dispute against Essity Hygiene and Health AB, a global leading hygiene and health company. The dispute regarded Lindex's period underwear, where Essity claimed that these should be classified as medical devices under the EU Medical Device Regulation (MDR) and require CE-marking.
Represents an international pharmaceutical company in a pending investigation carried out by the Swedish Competition Authority regarding alleged abuse of a dominant position due to an alleged excessive price.
Assisted Signet Healthcare Partners in connection with its investment in NorthX Biologics, a leading Nordic biopharmaceutical contract development and manufacturing organization (CDMO).
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Elisabeth Eklund; Mats Dahlberg
Other key lawyers
Magnus Berterud; Martin Bogg